Page 9 - Efficacy Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A woman being vaccinated in Ahmedabad. | Reuters/Amit Dave On Saturday, the pharmaceutical company Bharat Biotech officially announced the sale prices for its Covid-19 vaccine, Covaxin. State governments will have to pay Rs 600 per dose while private hospitals will have to pay Rs 1,200 per dose. These prices, fixed far above the corresponding rates announced by the Serum Institute of India for its vaccine, Covishield, has surprised observers for many reasons. The Serum Institute could cite royalty payments to the Swedish-Britsh firm AstraZeneca from which it has licensed i...

Moderna Reports Shortfall; Merkel Gets Astra Shot: Virus Update Bloomberg 52 mins ago Bloomberg News (Bloomberg) -- Moderna Inc. said it will deliver less Covid-19 vaccine than planned to the U.K., Canada and other countries this quarter due to a shortfall in doses in its European supply chain. China is planning to approve its first foreign vaccine before July, according to people familiar with the matter. German Chancellor Angela Merkel got her first shot of the AstraZeneca vaccine, despite possible links to rare blood clots that have led to its use being limited in some co...

Dr Maha Hussain at the recent virtual ASCO Meeting. Credit: ASCO Second look analysing prostate cancer study data reaps new rewards Two studies unveiled at last month’s virtual Genitourinary Cancers Symposium, organised by the American Society of Clinical Oncology, will have implications for both the treatment of prostate cancer and the provision of screening, Peter Doyle reports In men with non-metastatic castration-resistant prostate cancer (nmCRPC) and rapidly rising prostate specific antigen (PSA) treated with androgen deprivation therapy (ADT) plus enzalutamide (ENZA), there was a clo...

Feb 24, 2021 Making TCAR available for select patients leads to 10% lower MACE rates Hospitals that adopted transcarotid artery revascularization (TCAR) as an option for carotid revascularization saw a 10% reduction in perioperative major adverse cardiovascular events (MACE) in patients with carotid artery stenosis, according to a registry-based study, although other quality-of-care initiatives may also have played a part. In a study of data from the Society of Vascular Surgery’s Vascular Quality Initiative (VQI), the crude rate of MACE was similar for post-TCAR and post-CEA at 2.3% versus ...

Trial PROSPERs China’s fight against advancing prostate cancer New results from the PROSPER trial helped persuade the Chinese government to approve enzalutamide for adult patients diagnosed with advanced non-metastatic castration-resistant prostate cancer, Peter Doyle reports It might be coincidental. But eight months after a joint study by the Peking First University Hospital and National Urological Cancer Center of China in Beijing found a lack of effective therapies in the world’s most populous country for patients with advanced prostate cancer, China’s medicine regulator, the Natio...